Objectives: Outpatients given antidepressants discontinue treatment at a high rate during the first few months. We evaluated the effectiveness of Highmark's use of interactive voice response (IVR) to improve antidepressant medication adherence.
Study Design: Quasi-experimental cohort intervention study.
Methods: We placed 39,020 members newly given antidepressant medication into 3 intervention groups based on results of interactive voice response (IVR) call 1 month post-prescription: (1) not reached; (2) reached but not transferred to depression management consultant (DMC); and (3) reached and transferred to DMC. We evaluated medication adherence based on the Healthcare Effectiveness Data and Information Set effective acute phase (3 months) and continuation phase (6 months) treatment outcomes using member claims data. We used generalized estimating equations to model intervention effectiveness on medication adherence.
Results: Adherence increased markedly with age group, with members older than 65 years having a 5.11-fold higher odds (P <.0001) of compliance than the baseline group aged 18 to 24 years. In models adjusted for time, month of intervention, and drug, the odds of compliance for groups (3) and (2) relative to group (1) were 1.34 (P = .009) and 1.19 (P <.001), respectively. In models also adjusted for age group, the group (3) and (2) odds decreased to 1.00 and 1.03 and were not statistically significant.
Conclusions: We found that IVR calls had little impact on antidepressant medication adherence rates. Adherence rates increased markedly with increasing age in each intervention group, suggesting that other intervention strategies to improve adherence should focus on the younger segment of the patient population.
Download full-text PDF |
Source |
---|
Arch Dermatol Res
January 2025
Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
We have recently shown that fluoxetine (FX) suppressed polyinosinic-polycytidylic acid-induced inflammatory response and endothelin release in human epidermal keratinocytes, via the indirect inhibition of the phosphoinositide 3-kinase (PI3K)-pathway. Because PI3K-signaling is a positive regulator of the proliferation, in the current, highly focused follow-up study, we assessed the effects of FX (14 µM) on the proliferation and differentiation of human epidermal keratinocytes. We found that FX exerted anti-proliferative actions in 2D cultures (HaCaT and primary human epidermal keratinocytes [NHEKs]; 48- and 72-h; CyQUANT-assay) as well as in 3D reconstructed epidermal equivalents (48-h; Ki-67 immunohistochemistry).
View Article and Find Full Text PDFCell Chem Biol
January 2025
Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address:
The epidermal barrier defends the body against dehydration and harmful substances. The commensal microbiota is essential for proper differentiation and repair of the epidermal barrier, an effect mediated by the aryl hydrocarbon receptor (AHR). However, the microbial mechanisms of AHR activation in skin are less understood.
View Article and Find Full Text PDFIn an interview with Samantha Nelson, a scientific editor of Cell Chemical Biology, the authors of the research article entitled "Commensal-derived tryptophan metabolites fortify the skin barrier: Insights from a 50-species gnotobiotic model of human skin microbiome" share insights about their paper, field, and lives as scientists.
View Article and Find Full Text PDFAnn Med
December 2025
Department of Anesthesiology, Hunan Children's Hospital, Changsha, Hunan, China.
Introduction: Esketamine has unique advantages in combination with dexmedetomidine for sedation in young children, owing to its sympathetic activity and mild respiratory depression. However, the optimal dose is yet to be determined. In this study, we compared the different doses of intranasal esketamine combined with dexmedetomidine for sedation during transthoracic echocardiography in toddlers.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Department of Behavioural Science and Health, University College London, London, United Kingdom.
Importance: A wide range of medications, noncombustible nicotine products, behavioral support, and alternative treatments are available in England to help people stop smoking. Understanding their effectiveness outside of clinical trial settings can support informed decision-making.
Objectives: To provide up-to-date estimates of the prevalence of different smoking cessation aids and associations with quit success and to explore moderation by socioeconomic position.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!